A Phase I/II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Initial Efficacy of JS212 in Subjects With Advanced Malignant Solid Tumour
Clinical trial NCT06888830 · RECRUITING
Trial details
- NCT number
- NCT06888830
- Sponsor
- Shanghai Junshi Bioscience Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-11
- Primary completion
- 2027-12-31
- Enrollment
- 374
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.